Alembic Pharmaceuticals announces US FDA final approval for formoterol fumarate inhalation solution
This ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Orbicular Pharmaceutical Technologies
Alembic Pharma in JV agreement with Orbicular
To develop and commercialise dermatology products for global markets